Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1997 Nov;110(2):174–181. doi: 10.1111/j.1365-2249.1997.tb08314.x

Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients

V THON *,†, H M WOLF *, M SASGARY *, J LITZMAN †, A SAMSTAG *, I HAUBER *, J LOKAJ †, M M EIBL *
PMCID: PMC2265506  PMID: 9367399

Abstract

CVID is characterized by hypogammaglobulinaemia and impaired antibody production. Previous studies demonstrated defects at the T cell level. In the present study the response of purified CD4+ and CD8+ T lymphocytes to stimulation with anti-TCR monoclonal antibody (the first signal) in combination with anti-CD4 or anti-CD8, anti-CD2 and anti-CD28 MoAbs (the costimulatory signals) was investigated. Both CD4+ and CD8+ T cells from the patients showed significantly reduced IL-2 release following stimulation via TCR and costimulation via CD4 or CD8 and CD2, respectively. However, normal IL-2 production following TCR plus phorbol myristate acetate (PMA) costimulation and normal expression of an early activation marker, CD69, after TCR + CD28 stimulation indicated that TCR was able to transduce a signal. Furthermore, both IL-2 and IL-4 release were impaired in CD4+ lymphocytes following TCR + CD28 stimulation. In addition, stimulation via TCR + CD28 resulted in significantly decreased expression of CD40 ligand in the patients. These results suggest that the integration of activating signals derived from the TCR and costimulatory molecules is defective in CVID patients; the defect is not confined to costimulation via a single molecule, or restricted to cells producing Thl-type cytokines such as IL-2, and is expressed in both CD4+ and CD8+T cell subsets.

Keywords: common variable immunodeficiency, activation, costimulation, T cell receptor, CD40 ligand

Full Text

The Full Text of this article is available as a PDF (802.1 KB).

References

  • 1.Rosen FS, Wedgwood JP, Eibl M, et al. Primary Immunodeficiency Diseases. Report of a WHO Scientific Group. Clin Exp Immunol. 1995;99(Suppl. l):1–24. [PMC free article] [PubMed] [Google Scholar]
  • 2.Saxon A, Sidell N, Zhang K. B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation. Cell Immunol. 1992;144:169–81. doi: 10.1016/0008-8749(92)90234-g. [DOI] [PubMed] [Google Scholar]
  • 3.Nonoyama S, Farrington M, Ishida H, Howard M, Ochs HD. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J Clin Invest. 1993;92:1282–7. doi: 10.1172/JCI116701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Eisenstein EM, Chua K, Strober W. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J Immunol. 1994;152:5957–68. [PubMed] [Google Scholar]
  • 5.Sneller MC, Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol. 1990;144:3762–9. [PubMed] [Google Scholar]
  • 6.Eisenstein EM, Jaffe JS, Strober W. Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation. J Clin Immunol. 1993;13:247–58. doi: 10.1007/BF00919383. [DOI] [PubMed] [Google Scholar]
  • 7.North ME, Webster AD, Farrant J. Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C. Clin Exp Immunol. 1991;85:198–201. doi: 10.1111/j.1365-2249.1991.tb05704.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fischer MB, Hauber I, Vogel E, Wolf HM, Mannhalter JW, Eibl MM. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol. 1993;92:340–52. doi: 10.1016/0091-6749(93)90178-i. [DOI] [PubMed] [Google Scholar]
  • 9.Stagg AJ, Funauchi M, Knight SC, Webster AD, Farrant J. Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID) Clin Exp Immunol. 1994;96:48–53. doi: 10.1111/j.1365-2249.1994.tb06228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fischer MB, Hauber I, Eggenbauer H, et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood. 1994;84:4234–41. [PubMed] [Google Scholar]
  • 11.Janeway CA, Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 1994;76:275–85. doi: 10.1016/0092-8674(94)90335-2. [DOI] [PubMed] [Google Scholar]
  • 12.Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol. 1989;7:445–80. doi: 10.1146/annurev.iy.07.040189.002305. [DOI] [PubMed] [Google Scholar]
  • 13.Bierer BE, Burakoff SJ. T cell receptors: adhesion and signaling. Adv Cancer Res. 1991;56:49–76. doi: 10.1016/s0065-230x(08)60477-7. [DOI] [PubMed] [Google Scholar]
  • 14.Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today. 1992;13:431–3. doi: 10.1016/0167-5699(92)90068-I. [DOI] [PubMed] [Google Scholar]
  • 15.Geha RS, Rosen FS. The genetic basis of immunoglobulin-class switching [editorial] N Engl J Med. 1994;330:1008–9. doi: 10.1056/NEJM199404073301412. [DOI] [PubMed] [Google Scholar]
  • 16.Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today. 1994;15:406–11. doi: 10.1016/0167-5699(94)90269-0. [DOI] [PubMed] [Google Scholar]
  • 17.Noelle RJ. The role of gp39 (CD40L) in immunity. Clin Immunol Immunopathol. 1995;76:S203–7. doi: 10.1016/s0090-1229(95)90234-1. [DOI] [PubMed] [Google Scholar]
  • 18.Gordon J. CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev. 1995;9:53–56. doi: 10.1016/0268-960x(95)90040-3. [DOI] [PubMed] [Google Scholar]
  • 19.Fuleihan R, Ramesh N, Loh R, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA. 1993;90:2170–3. doi: 10.1073/pnas.90.6.2170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Korthaäer U, Graf D, Mages HW, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:539–41. doi: 10.1038/361539a0. [DOI] [PubMed] [Google Scholar]
  • 21.Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291–300. doi: 10.1016/0092-8674(93)90668-g. [DOI] [PubMed] [Google Scholar]
  • 22.Farrington M, Grosmaire LS, Nonoyama S, et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA. 1994;91:1099–103. doi: 10.1073/pnas.91.3.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ruegg CL, Rajasekar S, Stein BS, Engleman EG. Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. Evidence for distinct endocytic routing of CD4 and CD3. J Biol Chem. 1992;267:18837–43. [PubMed] [Google Scholar]
  • 24.Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DANN and proteins from cell and tissue samples. BioTechniques. 1993;15:532–4. [PubMed] [Google Scholar]
  • 25.Hollenbaugh D, Grosmaire LS, Kullas CD, et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J. 1992;11:4313–21. doi: 10.1002/j.1460-2075.1992.tb05530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Foley KP, Leonard MW, Engel JD. Quantitation of RNA using the polymerase chain reaction. Trends Genet. 1993;9:380–5. doi: 10.1016/0168-9525(93)90137-7. [DOI] [PubMed] [Google Scholar]
  • 27.Conlon KC, Ochoa AC, Kopp WC, Ortaldo JR, Urba WJ, Longo DL, Young HA. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes. J Immunol. 1992;149:3278–89. [PubMed] [Google Scholar]
  • 28.Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science. 1991;251:313–6. doi: 10.1126/science.1846244. [DOI] [PubMed] [Google Scholar]
  • 29.Fraser JD, Weiss A. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol Cell Biol. 1992;12:4357–63. doi: 10.1128/mcb.12.10.4357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol. 1995;7:333–42. doi: 10.1016/0952-7915(95)80107-3. [DOI] [PubMed] [Google Scholar]
  • 31.Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol. 1994;152:5643–52. [PubMed] [Google Scholar]
  • 32.Keightley RG, Cooper MD, Lawton AR. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol. 1976;117:1538–44. [PubMed] [Google Scholar]
  • 33.Tsuji T, Nibu R, Iwai K, Kanegane H, Yachie A, Seki H, Miyawaki T, Taniguchi N. Efficient induction of immunoglobulin production in neonatal naive B cells by memory CD4+ T cell subset expressing homing-receptor L-selectin. J Immunol. 1994;152:4417–24. [PubMed] [Google Scholar]
  • 34.Fischer MB, Wolf HM, Eggenbauer H, et al. The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency. Clin Exp Immunol. 1994;95:209–14. doi: 10.1111/j.1365-2249.1994.tb06512.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Funauchi M, Farrant J, Moreno C, Webster AD. Defects in antigen-driven lymphocyte responses in common variable immunodeficiency (CVED) are due to a reduction in the number of antigen-specific CD4+ T cells. Clin Exp Immunol. 1995;101:82–88. doi: 10.1111/j.1365-2249.1995.tb02281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Waldmann TA, Durm M, Broder S, Blackman M, Blaese RM, Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet. 1974;2:609–13. doi: 10.1016/s0140-6736(74)91940-0. [DOI] [PubMed] [Google Scholar]
  • 37.Broom BC, De la Concha EG, Webster AD, Janossy GJ, Asherson GL. Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes. Clin Exp Immunol. 1976;23:73–77. [PMC free article] [PubMed] [Google Scholar]
  • 38.De la Concha EG, Oldham G, Webster AD, Asherson GL, Platts-Mills TA. Quantitative measurements of T- and B-cell function in ‘variable’ primary hypogammaglobulinaemia: evidence for a consistent B-cell defect. Clin Exp Immunol. 1977;27:208–15. [PMC free article] [PubMed] [Google Scholar]
  • 39.Jaffe JS, Strober W, Sneller MC. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood. 1993;82:192–200. [PubMed] [Google Scholar]
  • 40.Jaffe JS, Eisenstein E, Sneller MC, Strober W. T-cell abnormalities in common variable immunodeficiency. Pediatr Res. 1993;33:S24–27. doi: 10.1203/00006450-199305001-00128. [DOI] [PubMed] [Google Scholar]
  • 41.North ME, Akbar AN, Borthwick N, Sagawa K, Funauchi M, Webster AD, Farrant J. Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency. Clin Exp Immunol. 1994;95:204–8. doi: 10.1111/j.1365-2249.1994.tb06511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Pastor MI, Reif K, Cantrell D. The regulation and function of p21ras during T-cell activation and growth. Immunol Today. 1995;16:159–64. doi: 10.1016/0167-5699(95)80134-0. [DOI] [PubMed] [Google Scholar]
  • 43.D'Ambrosio D, Cantrell DA, Frati L, Santoni A, Testi R. Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol. 1994;24:616–20. doi: 10.1002/eji.1830240319. [DOI] [PubMed] [Google Scholar]
  • 44.Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today. 1994;15:479–83. doi: 10.1016/0167-5699(94)90193-7. [DOI] [PubMed] [Google Scholar]
  • 45.Fuleihan R, Ramesh N, Horner A, et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest. 1994;93:1315–20. doi: 10.1172/JCI117089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Fuleihan R, Ahem D, Geha RS. Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switching. Int Arch Allergy Immunol. 1995;107:43–44. doi: 10.1159/000236925. [DOI] [PubMed] [Google Scholar]
  • 47.Fischer MB, Wolf HM, Hauber I, Eggenbauer H, Thon V, Sasgary M, Eibl MM. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol. 1996;26:231–7. doi: 10.1002/eji.1830260136. [DOI] [PubMed] [Google Scholar]
  • 48.Spickett GP, Farrant J, North ME, Zhang J-G, Morgan L, Webster ADB. Common variable immunodeficiency: how many diseases. Immunol Today. 1997;18:325–8. doi: 10.1016/s0167-5699(97)01086-4. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES